Search the Site
Skip Links


Invokana – Amputation

Invokana (canagliflozin) belongs to a new class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. Normally, when a person eats, the body produces insulin to process sugar that enters the body. In people with Type 2 diabetes, this response no longer works the way it should, and they develop insulin resistance. Eventually, the pancreas cannot keep up with the demand for insulin, and sugar levels rise to dangerous levels. Invokana and other SGLT2 inhibitors work by preventing sugar from being reabsorbed into the blood.

Possible Personal Injury: Diabetic Ketoacidosis (DKA).

Patients who have taken Invokana have to be vigilant for any signs of diabetic ketoacidosis (DKA), which is considered a medical emergency. Symptoms include confusion, difficulty breathing, unusual fatigue or sleepiness, frequent urination or thirst that lasts for a day or more, flushed face, fruity-smelling breath, aching muscles, or muscle stiffness, vomiting, nausea, and stomach pain. Victims of Invokana have identified the following personal injuries caused by the product:

  • Foot Amputation
  • Leg Amputation
  • Toe Amputation
  • Colon Cancer

History of Invokana

In March 2013, the FDA approved Johnson & Johnson’s Invokana, and it was the first in its class. Then, in 2014, the FDA approved Invokamet (canagliflozin and metformin). However, in May 2015, the agency issued a drug safety communication that warned patients and doctors that these drugs may lead to DKA.

Warning symptoms of the condition include nausea, vomiting, difficulty breathing, confusion, abdominal pain, and unusual fatigue or sleepiness. The FDA urges patients who are taking SGLT2s and are suffering from these symptoms to seek medical attention immediately.

Case Status

According to the most recent quarterly report by Johnson & Johnson, the company is facing approximately 1,100 Invokana lawsuits, and that number is likely to grow. More than 950 of these cases have been filed in various federal district courts throughout the country, but some of them have also been filed in state courts, primarily in California, Pennsylvania, and New Jersey.

Federal Invokana lawsuits have been organized into multidistrict litigation (MDL) in the U.S. District Court for the District of New Jersey under the designation MDL 2750. The MDL process makes it more efficient to handle many legal complaints that are the same or similar, and it has been used frequently to handle defective drugs, medical devices, and consumer products. As of early 2018, cases in MDL 2750 were still going through the pretrial discovery phase, with the first Invokana trial began in September 2018.

Why Beacon Legal Group Should Be Your Personal Injury Attorney

BLG maintains a team of specially trained professionals to guide you through your Invokana personal injury lawsuit. You may be entitled to compensation for medical expenses, lost wages, permanent impairments suffered, pain and suffering, and even punitive damages where appropriate.

BLG Fees and Costs

BLG covers all fees and costs to pursue your Invokana case. We only collect our fees and costs if we win for you through a settlement or a judgment.

Free Case Evaluation

BLG will evaluate your personal injury case with no obligation on your part. We only invite you to be our client if we believe your case has merit.

If you or someone you love suffered from Invokana side effects, you may be eligible for compensation. Submit your request for a free case evaluation now. We have a team of caring and compassionate Invokana lawsuit attorneys ready to help.

Connect with us